Clinuvel Pharmaceuticals (CLVLY) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CLVLY Stock Alerts $9.46 -0.29 (-2.97%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePhotomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investorsglobenewswire.com - March 28 at 4:25 AMClinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years agofinance.yahoo.com - March 21 at 9:00 PMClinuvel Pharmaceuticals Ltd ADR (CLVLY)investing.com - March 20 at 2:57 PMThe Clinuvel Pharmaceuticals share price is up 236% in 12 monthsfool.com.au - March 9 at 11:12 PMMalibu shines a light on CLINUVEL's pioneering work in photomedicineglobenewswire.com - March 4 at 9:38 PMClinuvel Pharmaceuticals Ltd. ADRwsj.com - March 2 at 12:29 PMClinuvel Pharmaceuticals (CLVLF) Price Target Increased by 5.58% to 19.75msn.com - February 25 at 10:31 AMClinuvel Pharmaceuticals GAAP EPS of A$0.22, revenue of A$32.25Bmsn.com - February 23 at 10:45 AMClinuvel Pharmaceuticals Ltd.wsj.com - January 30 at 10:12 AMClinuvel Pharmaceuticals Ltd ADRmorningstar.com - December 9 at 2:12 PMClinuvel Pharmaceuticals Ltd ADR CLVLYmorningstar.com - December 2 at 10:34 AMClinuvel Pharmaceuticals Ltd - ADR (CLVLY) Price Target Increased by 18.27% to 21.08nasdaq.com - October 31 at 7:09 PMClinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 38% loss from investing in the stock three years agofinance.yahoo.com - October 5 at 11:57 PMClinuvel Pharmaceuticals (CLVLF) Price Target Increased by 12.19% to 18.70msn.com - September 1 at 6:11 PMCould The Market Be Wrong About Clinuvel Pharmaceuticals Limited (ASX:CUV) Given Its Attractive Financial Prospects?finance.yahoo.com - May 3 at 6:14 PMSome Patients With a Rare Disease Face Hurdles Getting the Only Treatmentmsn.com - May 1 at 1:09 PMClinuvel Pharmaceuticals (ASX:CUV) shareholders have earned a 14% CAGR over the last five yearsfinance.yahoo.com - March 30 at 7:53 PMAnalysts Just Slashed Their Clinuvel Pharmaceuticals Limited (ASX:CUV) EPS Numbersfinance.yahoo.com - March 1 at 1:04 AMCLINUVEL Launches CYACÊLLE, Next Generation Solar Carefinance.yahoo.com - March 1 at 1:04 AMWhy Clinuvel, Cogstate, Omni Bridgeway, and Westgold shares are sinkingmsn.com - February 25 at 4:47 PMClinuvel Pharmaceuticals First Half 2023 Earnings: EPS: AU$0.23 (vs AU$0.12 in 1H 2022)finance.yahoo.com - February 24 at 6:49 PMClinuvel Pharmaceuticals Limited: Global SCENESSE demand drives increased CLINUVEL revenues, earningsfinanznachrichten.de - February 24 at 1:49 PMGlobal SCENESSE® demand drives increased CLINUVEL revenues, earningsfinance.yahoo.com - February 23 at 8:39 PMClinuvel Pharmaceuticals Limited: CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individualsfinanznachrichten.de - February 2 at 10:14 AMCLINUVEL Trial Results Show Drug Reduces DNA Damagefinance.yahoo.com - January 15 at 8:21 PMClinuvel Pharmaceuticals' (ASX:CUV) earnings growth rate lags the 25% CAGR delivered to shareholdersfinance.yahoo.com - September 19 at 8:13 PMCLVLY Clinuvel Pharmaceuticals Limitedseekingalpha.com - June 17 at 10:10 PMDo Insiders Own Lots Of Shares In Clinuvel Pharmaceuticals Limited (ASX:CUV)?finance.yahoo.com - May 16 at 2:52 AMCLINUVEL progresses vitiligo treatment programfinance.yahoo.com - May 10 at 12:07 AMLetter to shareholders from CLINUVEL's CEOstockhouse.com - April 29 at 2:22 AMLetter to shareholders from CLINUVEL’s CEOfinance.yahoo.com - April 29 at 2:22 AMClinuvel Pharmaceuticals' (ASX:CUV) investors will be pleased with their solid 139% return over the last five yearsfinance.yahoo.com - April 12 at 9:03 PMClinuvel Pharmaceuticals reports 1H resultsseekingalpha.com - February 23 at 2:04 PMWhat Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?finance.yahoo.com - December 3 at 6:37 PMClinuvel Pharmaceuticals Limited (CLVLY)au.finance.yahoo.com - September 3 at 11:19 PM Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVLY and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. CLVLY Media Mentions By Week CLVLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLVLY News Sentiment▼0.000.41▲Average Medical News Sentiment CLVLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLVLY Articles This Week▼10▲CLVLY Articles Average Week Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CLVLY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinuvel Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
